Sean Whelan - 17 Mar 2025 Form 4 Insider Report for Zomedica Corp. (ZOMDF)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
18 Nov 2025, 16:45:36 UTC
Prior SEC filing
13 Nov 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Sean Whelan

Key filing fact

Sean Whelan filed Form 4 for Zomedica Corp. (ZOMDF) on 18 Nov 2025.

Key facts

  • This page summarizes Sean Whelan's Form 4 filing for Zomedica Corp. (ZOMDF).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 18 Nov 2025, 16:45.

Change

  • Previous filing in this sequence was filed on 13 Nov 2024.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001418307 Primary reporting owner

Whelan Sean

Relationship
Director
Address
1101 TECHNOLOGY DRIVE, STE 100, ANN ARBOR
Signature
/s/ Sean Whelan
Signature date
18 Nov 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ZOMDF transaction Derivative

Stock Appreciation Right

Award

Transaction value
$0
Shares
+1,975,033
Change %
Price
$0.000000
Shares after
1,975,033
Date
17 Nov 2025
Ownership
Direct
Underlying class
Common
Underlying amount
1,975,033
Exercise price
$0.1000
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .